Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5

Voglibite-M 0.3 Tablet SR

Prescription Icon
Prescription Required

Marketer

Corona Remedies Pvt Ltd

Salt Composition

Metformin (500mg) + Voglibose (0.3mg)

Overview Voglibite-M 0.3 Tablet SR

Voglibite-M 0.3 SR tablets are classified as antidiabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose levels. Voglibite-M 0.3 SR tablets should be administered with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with well-controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to complications such as nephropathy, retinopathy, neuropathy, and peripheral vascular disease. This medication forms part of a comprehensive diabetes management plan encompassing diet modification, regular physical activity, and weight management as directed by your healthcare provider. Lifestyle choices significantly influence diabetes control. Potential side effects, including nausea, altered taste perception, anorexia, flatulence, abdominal discomfort, diarrhea, and skin rashes, are generally transient and self-limiting. Persistent or concerning side effects warrant immediate medical consultation. Your doctor can provide strategies to manage or treat troublesome side effects. This medication is contraindicated in patients with type 1 diabetes mellitus, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment, as suitability may be affected. Pregnant or lactating individuals must consult their physician before initiating this medication. Regular blood glucose monitoring is essential, and your doctor may order blood tests to assess blood cell counts and liver function.

Uses of Voglibite-M 0.3 Tablet SR

Managing type 2 diabetes

Major Benefits of Voglibite-M 0.3 Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Voglibite-M 0.3mg Extended-Release Tablet should be taken with a meal.

Common Side effects of Voglibite-M 0.3 Tablet SR:

  • Flatulence
  • Diarrhea
  • Abdominal pain
  • Vomiting
  • Decreased appetite

How to use Voglibite-M 0.3 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Voglibite-M 0.3 Tablet SR whole; avoid chewing, crushing, or breaking it. Consume this extended-release tablet with food.

How Voglibite-M 0.3 Tablet SR works:

Voglibite-M 0.3mg extended-release tablets contain a dual antidiabetic medication formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Voglibite-M 0.3 Tablet SR and alcohol is not recommended due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Voglibite-M 0.3 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Voglibite-M 0.3mg tablets are likely unsafe for use while breastfeeding. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingSAFE

The extended-release Voglibite-M 0.3mg tablet typically doesn't impair driving ability. Nevertheless, patients should be aware of the potential for low blood sugar (hypoglycemia) if taken concurrently with other diabetes medications like sulfonylureas, insulin, or repaglinide.

KidneyKidneyCAUTION

Patients with kidney impairment should use Voglibite-M 0.3 Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Physician consultation is necessary. Regular monitoring of renal function is recommended during treatment.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding Voglibite-M 0.3 Tablet SR use in individuals with hepatic impairment. Seek medical advice from your physician.

What if you forget to take Voglibite-M 0.3 Tablet SR :

Should you forget a dose of Voglibite-M 0.3 SR Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Voglibite-M 0.3 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management
Voglibite-M 0.3 Tablet SR
80
MRP 97
17% off